Detalhe da pesquisa
1.
Mirikizumab: A New Therapeutic Option for the Treatment of Ulcerative Colitis.
Ann Pharmacother
; : 10600280241229742, 2024 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38344998
2.
Etrasimod: A Sphingosine-1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis.
Ann Pharmacother
; : 10600280231225770, 2024 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38258760
3.
Biosimilars in IBD: What Every Clinician Needs to Know.
Curr Gastroenterol Rep
; 26(3): 77-85, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38243154
4.
Peri-Operative Optimization of Patients with Crohn's Disease.
Curr Gastroenterol Rep
; 26(5): 125-136, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38421577
5.
Risankizumab-rzaa: A New Therapeutic Option for the Treatment of Crohn's Disease.
Ann Pharmacother
; 57(5): 579-584, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36214282
6.
Pharmacist-Managed Helicobacter pylori Treatment Service Within a Gastroenterology Clinic: Workflow and Real-World Experiences.
Ann Pharmacother
; 56(2): 162-169, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34049441
7.
Safety of Rapid Infliximab Biosimilar Infusions in Patients With Inflammatory Bowel Disease.
Ann Pharmacother
; 56(3): 280-284, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34192881
8.
Ozanimod: A First-in-Class Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis.
Ann Pharmacother
; 56(5): 592-599, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34423657
9.
Adalimumab-Adbm: The First Interchangeable Biosimilar for the Treatment of Inflammatory Diseases.
Ann Pharmacother
; 56(12): 1356-1364, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-35392668
10.
Does Similarity Breed Contempt? A Review of the Use of Biosimilars in Inflammatory Bowel Disease.
Dig Dis Sci
; 66(8): 2513-2532, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34176024
11.
Impact of Clinical Pharmacists in Inflammatory Bowel Disease Centers During the COVID-19 Pandemic.
Am J Gastroenterol
; 115(9): 1532-1533, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32694291
12.
How to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients With Inflammatory Bowel Disease and Chronic Liver Disease.
Gastroenterology
; 164(7): 1047-1051, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33460608
13.
Rapid Adoption of Pneumococcal 20-Valent Conjugate Vaccination in Adult Patients With Inflammatory Bowel Disease: An Analysis One Year After Availability.
J Clin Gastroenterol
; 58(2): 207-209, 2024 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38047595
14.
Factors influencing the acceptance of referrals for clinical pharmacist managed disease states in primary care.
J Am Pharm Assoc (2003)
; 59(3): 336-342, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30948239
15.
Outcomes of a Pharmacist-Managed Heart Failure Medication Titration Assistance Clinic.
Ann Pharmacother
; 52(8): 724-732, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29463107
16.
Roles of Clinical Pharmacists in Caring for Patients With Inflammatory Bowel Disease During COVID-19.
Gastroenterology
; 160(5): 1880, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32425232
17.
Designing and validation of a yoga-based intervention for obsessive compulsive disorder.
Int Rev Psychiatry
; 28(3): 327-33, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27117898
18.
Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies.
Inflamm Bowel Dis
; 2023 Jul 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37450619
19.
Preparing for the market entry of adalimumab biosimilars in the US in 2023: A primer for specialty pharmacists.
Am J Health Syst Pharm
; 80(18): 1223-1233, 2023 09 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37257054
20.
Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA Consensus.
Inflamm Bowel Dis
; 2023 Aug 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37650888